Recommendations for the assessment of metabolic dysfunction-associated fatty liver disease (MAFLD)

Recommendations for the assessment of metabolic dysfunction-associated fatty liver disease (MAFLD) in primary care: a consensus statement

MAFLD is estimated to affect one in three Australian adults, and this Consensus Statement provides an evidence-based document for GPs, to support the assessment and referral of adults with MAFLD.

^{This resource is accepted by the RACGP.}